| Financial Year |
March 31 2023 |
| Monetary Funds |
1,742,697,314.55 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
190,308,675.48 |
| Advances to Suppliers |
161,273,418.30 |
| Other Receivables |
55,667,132.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
467,718,914.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
170,501,345.92 |
| Total Current Assets |
3,070,837,708.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
602,641,245.89 |
| Under-construction Projects |
422,569,661.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
97,055,054.88 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
10,946,944.92 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,133,933,788.67 |
| Total Assets |
4,204,771,497.37 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,782,955,591.05 |
| Accounts Payable |
51,474,755.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,039,995.49 |
| Taxes Payable |
9,410,900.70 |
| Interest Payable |
868,989.14 |
| Dividend Payable |
-- |
| Other payables |
4,471,902.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
712,287.82 |
| Other Current Liabilities |
11,416,672.49 |
| Sub-Total of Current Liabilities |
1,987,942,836.92 |
| Long-term Loans |
186,375,909.25 |
| Bonds Payable |
178,988,538.05 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
30,936.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
389,727,264.61 |
| Total Liabilities |
2,377,670,101.53 |
| Paid-In Capital(Or Share Stock) |
315,556,832.00 |
| Capital Surplus |
502,409,893.29 |
| Surplus Reserve |
83,977,016.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
701,139,660.04 |
| Minority Stockholder's Interest |
196,151,968.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,630,949,427.72 |
| Owner's Equity（Stockholder's Equity） |
1,827,101,395.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,204,771,497.37 |
